MedTrace Logo

Analysis of Parameters Indicating the Intensity of Suicidal Behavior in Psychiatric Patients

NCT05803447 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2023-04-07

No results posted yet for this study

Summary

The aim of this study was to analyse the level of cognitive functioning of patients with history of suicidal behaviour suffering from depression and schizophrenia, and to evaluate their oxidative stress parameters and selected biochemical parameters on the basis of bloodwork.

Conditions

  • Suicidal Behaviour
  • Cognitive Functions Confusion

Interventions

OTHER

Interview questionnaire

An Interview questionnaire concerning an assessment of the intensity suicidal behavior, M.I.N.I. 7.0.2 was used. M.I.N.I. interview was conducted with each patient to verify the intensification of suicidal behaviour.

DIAGNOSTIC_TEST

biochemical parameters

The concentrations of the following parameters were determined from the: * blood serum: vitamin D3, B12, folic acid, sodium, potassium, calcium, magnesium, chlorine, total cholesterol, LDL and HDL fractions, TG * plasma: metabolites of the oxidative stress

DIAGNOSTIC_TEST

cognitive function

The participants completing cognitive function were assessed using computer CogState Test. The following cognitive functions were assessed: psychomotor drive (DET), metastability of attention (IDN), verbal memory, retrieval of learned material (ISLR) and verbal learning and memory (ISL), visual learning and memory (OCL), processing speed (GMCT), visual memory including deferred retrieval (GMR), executive functions (SETS and GML), working memory (ONB, TWOB).

Sponsors & Collaborators

  • Medical University of Bialystok

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-01
Primary Completion
2019-10-31
Completion
2019-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05803447 on ClinicalTrials.gov